Short Communication - Journal of Pharmaceutical Research and Clinical Practice (2020) Volume 3, Issue 3

Novelties in additive manufacturing and bioprinting

Abstract

The use of autologous materials such as platelet-rich fibrin (PRF) and advanced platelet-rich fibrin (A-PRF+) for enhancing wound healing and repairing damaged tissue is a reality. Patient’s own blood can be processed without addition of anticoagulants in order to obtain a tridimensional fibrin network containing platelets and leukocytes (including monocytes, lymphocytes, and granulocytes) that can act as a scaffold in the early phases of wound healing. It is reported that the interaction between these cells and the fibrin matrix stimulates a slow release of growth factors that may result in a better wound healing in the early phase of this process. PRF’s derivatives are widely used in oral surgery and periodontology. Bone defects in the patient’s jaws can be repaired, the wound healing can be improved. In vitro and in vivo studies shows advantages of these autologous materials in cells behavior and clinical wound healing outcome, but clinicians must be as well aware of their limitations.

Publication

Autologous pure platelet‐rich plasma injections for facial skin rejuvenation: Biometric instrumental evaluations and patient‐reported outcomes to support antiaging effects Plateletrich plasma injections for facial rejuvenation

Awards Nomination 20+ Million Readerbase

Select your language of interest to view the total content in your interested language


Google Scholar citation report
Citations : 67

Journal of Pharmaceutical Research and Clinical Practice received 67 citations as per Google Scholar report


Journal of Pharmaceutical Research and Clinical Practice peer review process verified at publons

Indexed In

flyer